Mutational Landscape in Myeloproliferative Neoplasms: Implications on Prognosis and Clinical Management
The diagnosis and management of patients with myeloproliferative neoplasms (MPN) has evolved since the identification of “driver” mutations, namely JAK2, CALR, and MPL mutations. Health care providers are challenged to stay abreast of new developments in the field that may help inform clinical decision-making.
  • Myeloproliferative Neoplasms
  • Recorded Webcast
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation